Viewing Study NCT03698227


Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2026-03-14 @ 7:55 AM
Study NCT ID: NCT03698227
Status: TERMINATED
Last Update Posted: 2020-07-15
First Post: 2018-10-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Soft Tissue Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Soft tissue sarcoma View